KING PHARMACEUTICALS (KG) P/E (2025 - 2026)
KING PHARMACEUTICALS (KG) P/E from May 28, 2025 to Jul 21, 2026. The TTM KING PHARMACEUTICALS (KG) P/E is -2.38. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of KING PHARMACEUTICALS (KG)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.38 | -24.67% |
| 2025 | -3.16 | N/A |
Comparison KING PHARMACEUTICALS (KG) P/E with competitors
KING PHARMACEUTICALS (KG) P/E is -2.38.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| HG | Hamilton Insurance Group Ltd - Class B | 3.82 | -260.65% |
| RNR | RenaissanceRe Holdings Ltd | 5.01 | -310.49% |
| SPNT | SiriusPoint Ltd | 5.65 | -337.71% |
| GLRE | Greenlight Capital Re Ltd - Class A | 6.79 | -385.57% |
| EG | Everest Group Ltd | 7.40 | -411.33% |
| RGA | Reinsurance Group Of America Inc | 14.67 | -716.66% |